secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-10-17T23:59:59+00:00
Accession:  0001104659-25-100455
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma grants 184,492 stock options to five executive officers at $3.01 strike
--------------------------------------------------------------------------------

- CEO Iain Dukes: 64,839 options; CFO Parker, CSO Pauza, CMO Redfield each 32,406; COO Savchuk 22,435.
- Exercise price $3.01/share (Oct 10 closing); 10-year term; full vest on first anniversary (Oct 12, 2026).
- Granted under Amended and Restated 2021 Incentive Compensation Plan; subject to continued service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925100455/0001104659-25-100455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925100455/tm2528641d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-100455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer